期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Midodrine和低温血液透析对透析中低血压的防治作用 被引量:6
1
作者 张晓良 王艳丽 +1 位作者 王辉 杨金芳 《现代医学》 2005年第2期82-86,共5页
目的 观察α1肾上腺素能受体激动剂米多君(midodrine)和低温血液透析(coolhemodialysis ,CHD)对透析中顽固性低血压(IDH)的防治作用。方法 应用前瞻性交叉设计,将12例IDH患者先后采用4种治疗方式,即空白对照、midodrine、CHD以及联合... 目的 观察α1肾上腺素能受体激动剂米多君(midodrine)和低温血液透析(coolhemodialysis ,CHD)对透析中顽固性低血压(IDH)的防治作用。方法 应用前瞻性交叉设计,将12例IDH患者先后采用4种治疗方式,即空白对照、midodrine、CHD以及联合治疗。观察血压、IDH干预次数、输注盐水量以及IDH相关症状严重程度的变化。结果 4组中透析前血压相似,3种治疗组的最低血压均显著高于对照组(P <0 .0 1) ,透析后血压与上述结果相似。IDH症状评分、生理盐水输入量以及IDH干预次数在3种治疗组均显著低于对照组(均P <0 .0 5 ) ,联合治疗组最低血压明显高于midodrine组和CHD组(均P <0 .0 5 ) ,未发现研究组间原有心脏病症状的恶化。结论 midodrine和CHD均可显著降低IDH发生率,改善IDH相关症状;两者联合应用可以进一步提高疗效,无明显副作用,值得临床推广。 展开更多
关键词 低温血液透析 midodrine 防治作用 低血压 midodrine 肾上腺素能受体激动剂 症状严重程度 IDH CHD 治疗组 交叉设计 方法应用 空白对照 治疗方式 联合治疗 症状评分 生理盐水 相关症状 对照组 米多君 顽固性 前瞻性 盐水量
下载PDF
Treatment of prolonged clonidine-induced autonomic instability with midodrine:a case report about a new approach or a cautionary tale?
2
作者 Saada Malouf Catherine Henry +1 位作者 Lara Pemberton Joe-Anthony Rotella 《Emergency and Critical Care Medicine》 2023年第4期194-197,共4页
Background:Clonidine is a centrally acting a2 adrenergic and imidazoline-1 receptor agonist that can cause somnolence,bradycardia,and hypotension within several hours of ingestion.Less well-described but observed by u... Background:Clonidine is a centrally acting a2 adrenergic and imidazoline-1 receptor agonist that can cause somnolence,bradycardia,and hypotension within several hours of ingestion.Less well-described but observed by us locally is the observation that patients presenting after large overdoses including clonidine can have prolonged autonomic instability.As a result,they may require many days in hospital before recovery.We have previously used midodrine as an indirect antagonist with good effect;however,there are no previous reports of its use for this indication.Case presentation:We present the case of a young female patient who developed prolonged autonomic instability following a large overdose of clonidine(coingested with smaller doses of escitalopram+lisdexamfetamine)that was treated with midodrine but complicated by a type 2 non-ST segment elevated myocardial infarction.Conclusion:Midodrine seems to ameliorate this protracted instability and may provide a means to decrease hospital length of stay in appropriate individuals. 展开更多
关键词 AUTONOMIC Case report CLONIDINE INSTABILITY midodrine OVERDOSE
原文传递
Oral blood pressure augmenting agents for intravenous vasopressor weaning
3
作者 John C Robinson Mariam ElSaban +1 位作者 Nathan J Smischney Patrick M Wieruszewski 《World Journal of Clinical Cases》 SCIE 2024年第36期6892-6904,共13页
Intravenous(IV)vasopressors are essential in the management of hypotension and shock.Initiation of oral vasoactive agents to facilitate weaning of IV vasopressors to liberate patients from the intensive care unit is c... Intravenous(IV)vasopressors are essential in the management of hypotension and shock.Initiation of oral vasoactive agents to facilitate weaning of IV vasopressors to liberate patients from the intensive care unit is common despite conflicting evidence regarding the benefits of this practice.While midodrine appears to be the most frequently studied oral vasoactive agent for this purpose,its adverse effect profile may preclude its use in certain populations.In addition,some patients may require persistent use of IV vasopressors for hypotension refractory to midodrine.The use of additional and alternative oral vasoactive agents bearing different mechanisms of action is emerging.This article provides a comprehensive review of the pharmacology,clinical uses,dosing strategies,and safety considerations of oral vasoactive agents and their application in the inten-sive care setting. 展开更多
关键词 VASOPRESSOR Shock HYPOTENSION midodrine DROXIDOPA ATOMOXETINE PSEUDOEPHEDRINE
下载PDF
Management and therapy of vasovagal syncope: A review 被引量:8
4
作者 Muhammet Ali Aydin Tushar V Salukhe +1 位作者 Iris Wilke Stephan Willems 《World Journal of Cardiology》 CAS 2010年第10期308-315,共8页
Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive e... Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial. 展开更多
关键词 VASOVAGAL SYNCOPE midodrine ADRENERGIC β-antagonists SEROTONIN uptake inhibitors
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部